Role of the Interaction of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells
- PMID: 35163403
- PMCID: PMC8835906
- DOI: 10.3390/ijms23031481
Role of the Interaction of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells
Abstract
Tumor necrosis factor-α (TNF-α) is a pleiotropic cytokine expressed by macrophages, monocytes, and T cells, and its expression is triggered by the immune system in response to pathogens and their products, such as endotoxins. TNF-α plays an important role in host defense by inducing inflammatory reactions such as phagocytes and cytocidal systems activation. TNF-α also plays an important role in bone metabolism and is associated with inflammatory bone diseases. TNF-α binds to two cell surface receptors, the 55kDa TNF receptor-1 (TNFR1) and the 75kDa TNF receptor-2 (TNFR2). Bone is in a constant state of turnover; it is continuously degraded and built via the process of bone remodeling, which results from the regulated balance between bone-resorbing osteoclasts, bone-forming osteoblasts, and the mechanosensory cell type osteocytes. Precise interactions between these cells maintain skeletal homeostasis. Studies have shown that TNF-α affects bone-related cells via TNFRs. Signaling through either receptor results in different outcomes in different cell types as well as in the same cell type. This review summarizes and discusses current research on the TNF-α and TNFR interaction and its role in bone-related cells.
Keywords: TNF receptor-1; TNF receptor-2; TNF-α; osteoblast; osteoclast; osteocyte.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation.Front Immunol. 2019 Dec 13;10:2925. doi: 10.3389/fimmu.2019.02925. eCollection 2019. Front Immunol. 2019. PMID: 31921183 Free PMC article.
-
Behavior of tumor necrosis factor-α and tumor necrosis factor receptor 1/tumor necrosis factor receptor 2 system in mononuclear cells recovered from peritoneal fluid of women with endometriosis at different stages.Reprod Sci. 2015 Feb;22(2):165-72. doi: 10.1177/1933719114536472. Epub 2014 May 20. Reprod Sci. 2015. PMID: 24844917 Free PMC article.
-
Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant.J Mol Biol. 2009 Jan 30;385(4):1221-9. doi: 10.1016/j.jmb.2008.11.053. Epub 2008 Dec 6. J Mol Biol. 2009. PMID: 19084540
-
Transmembrane TNF and Its Receptors TNFR1 and TNFR2 in Mycobacterial Infections.Int J Mol Sci. 2021 May 22;22(11):5461. doi: 10.3390/ijms22115461. Int J Mol Sci. 2021. PMID: 34067256 Free PMC article. Review.
-
TNF/TNFR: drug target for autoimmune diseases and immune-mediated inflammatory diseases.Front Biosci (Landmark Ed). 2014 Jun 1;19(7):1028-40. doi: 10.2741/4265. Front Biosci (Landmark Ed). 2014. PMID: 24896334 Review.
Cited by
-
TNF-α-induced Inhibition of Protein Myristoylation Via Binding Between NMT1 and Sorbs2 in Osteoblasts.In Vivo. 2024 Jan-Feb;38(1):107-113. doi: 10.21873/invivo.13416. In Vivo. 2024. PMID: 38148048 Free PMC article.
-
Global Publication Trends and Research Hotspots of the Immune System and Osteoporosis: A Bibliometric and Visualization Analysis from 2012 to 2022.Endocr Metab Immune Disord Drug Targets. 2024;24(4):455-467. doi: 10.2174/0118715303257269231011073100. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 37881072
-
The role of cytokines in the pathogenesis of SAPHO syndrome.Front Immunol. 2024 Sep 2;15:1427784. doi: 10.3389/fimmu.2024.1427784. eCollection 2024. Front Immunol. 2024. PMID: 39286247 Free PMC article. Review.
-
Nanoparticle-based approaches for vascular inflammation in managing hypertension: advancing molecular mechanisms and treatment strategies.Drug Deliv Transl Res. 2025 Jun 10. doi: 10.1007/s13346-025-01881-1. Online ahead of print. Drug Deliv Transl Res. 2025. PMID: 40495092 Review.
-
TNF receptor-associated factors: promising targets of natural products for the treatment of osteoporosis.Front Physiol. 2025 May 27;16:1527814. doi: 10.3389/fphys.2025.1527814. eCollection 2025. Front Physiol. 2025. PMID: 40496246 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources